These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
521 related articles for article (PubMed ID: 15879617)
21. Evaluation of autoimmune liver disease natural history in patients referred to Middle East Liver Diseases (MELD) center. Nejad SEM; Heiat M; Javanbakht M; Alavian SM; Haris MAA BMC Gastroenterol; 2024 Jan; 24(1):17. PubMed ID: 38178070 [TBL] [Abstract][Full Text] [Related]
25. [Clinical features of 35 cases of autoimmune hepatitis-primary biliary cirrhosis overlap syndrome]. Zeng Z; Han YK; Zhang XF; Geng H Zhonghua Gan Zang Bing Za Zhi; 2005 Jan; 13(1):3-5. PubMed ID: 15670480 [TBL] [Abstract][Full Text] [Related]
26. Primary biliary cirrhosis: overlaps with other autoimmune disorders. Floreani A; Franceschet I; Cazzagon N Semin Liver Dis; 2014 Aug; 34(3):352-60. PubMed ID: 25057958 [TBL] [Abstract][Full Text] [Related]
27. Autoimmune hepatitis and overlap syndromes. Dienes HP; Erberich H; Dries V; Schirmacher P; Lohse A Clin Liver Dis; 2002 May; 6(2):349-62, vi. PubMed ID: 12122860 [TBL] [Abstract][Full Text] [Related]
28. Clinical and biochemical features and therapy responses in primary biliary cirrhosis and primary biliary cirrhosis-autoimmune hepatitis overlap syndrome. Günsar F; Akarca US; Ersöz G; Karasu Z; Yüce G; Batur Y Hepatogastroenterology; 2002; 49(47):1195-200. PubMed ID: 12239904 [TBL] [Abstract][Full Text] [Related]
29. Worse Response to Ursodeoxycholic Acid in Primary Biliary Cholangitis Patients with Autoimmune Hepatitis Features. Wen M; Men R; Fan X; Shen Y; Ni P; Hu Z; Yang L Dig Dis; 2021; 39(4):366-374. PubMed ID: 33238269 [TBL] [Abstract][Full Text] [Related]
30. Primary biliary cirrhosis with additional features of autoimmune hepatitis: response to therapy with ursodeoxycholic acid. Joshi S; Cauch-Dudek K; Wanless IR; Lindor KD; Jorgensen R; Batts K; Heathcote EJ Hepatology; 2002 Feb; 35(2):409-13. PubMed ID: 11826416 [TBL] [Abstract][Full Text] [Related]
31. Overlap syndromes: the International Autoimmune Hepatitis Group (IAIHG) position statement on a controversial issue. Boberg KM; Chapman RW; Hirschfield GM; Lohse AW; Manns MP; Schrumpf E; J Hepatol; 2011 Feb; 54(2):374-85. PubMed ID: 21067838 [TBL] [Abstract][Full Text] [Related]
33. Combination therapy of ursodeoxycholic acid and budesonide for PBC-AIH overlap syndrome: a meta-analysis. Zhang H; Yang J; Zhu R; Zheng Y; Zhou Y; Dai W; Wang F; Chen K; Li J; Wang C; Li S; Liu T; Abudumijiti H; Zhou Z; Wang J; Lu W; Wang J; Xia Y; Zhou Y; Lu J; Guo C Drug Des Devel Ther; 2015; 9():567-74. PubMed ID: 25632224 [TBL] [Abstract][Full Text] [Related]
34. [Treatment of cholestatic liver diseases with ursodeoxycholic acid]. Boberg KM; Schrumpf E Tidsskr Nor Laegeforen; 1997 Sep; 117(23):3370-3. PubMed ID: 9411890 [TBL] [Abstract][Full Text] [Related]